LSERS
ALXN

Louisiana State Employees Retirement System’s Alexion Pharmaceuticals ALXN Stock Holding History

Louisiana State Employees Retirement System’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25,200
Closed -$4.63M – 1524
2021
Q2 		$4.63M Buy
25,200
+200
+0.8% +$34.3K 0.11% 136
2021
Q1 		$3.82M Buy
25,000
+1,800
+8% +$278K 0.1% 155
2020
Q4 		$3.63M Buy
23,200
+12,100
+109% +$1.55M 0.11% 155
2020
Q3 		$1.27M Buy
11,100
+1,600
+17% +$173K 0.06% 367
2020
Q2 		$1.07M Buy
9,500
+100
+1% +$10.6K 0.06% 358
2020
Q1 		$844K Sell
9,400
-1,100
-10% -$108K 0.06% 374
2019
Q4 		$1.14M Sell
10,500
-300
-3% -$32.1K 0.06% 416
2019
Q3 		$1.06M Sell
10,800
-400
-4% -$45.1K 0.06% 442
2019
Q2 		$1.35M Sell
11,200
-600
-5% -$77.3K 0.07% 323
2019
Q1 		$1.59M Buy
11,800
+100
+0.9% +$12.4K 0.08% 258
2018
Q4 		$1.14M Sell
11,700
-1,300
-10% -$154K 0.06% 349
2018
Q3 		$1.81M Sell
13,000
-100
-0.8% -$12.5K 0.08% 256
2018
Q2 		$1.63M Sell
13,100
-400
-3% -$46.7K 0.07% 277
2018
Q1 		$1.5M Hold
13,500
– – 0.07% 318
2017
Q4 		$1.61M Sell
13,500
-400
-3% -$48.7K 0.07% 279
2017
Q3 		$1.95M Hold
13,900
– – 0.09% 208
2017
Q2 		$1.69M Buy
13,900
+100
+0.7% +$11.6K 0.08% 246
2017
Q1 		$1.67M Sell
13,800
-300
-2% -$38.7K 0.08% 235
2016
Q4 		$1.73M Sell
14,100
-200
-1% -$24.5K 0.09% 219
2016
Q3 		$1.75M Sell
14,300
-400
-3% -$51.5K 0.09% 208
2016
Q2 		$1.72M Sell
14,700
-400
-3% -$56.8K 0.09% 212
2016
Q1 		$2.1M Sell
15,100
-700
-4% -$103K 0.11% 164
2015
Q4 		$3.01M Sell
15,800
-700
-4% -$122K 0.15% 103
2015
Q3 		$2.58M Buy
16,500
+200
+1% +$36.5K 0.13% 125
2015
Q2 		$2.95M Buy
16,300
+1,700
+12% +$293K 0.14% 115
2015
Q1 		$2.53M Sell
14,600
-300
-2% -$54.3K 0.12% 138
2014
Q4 		$2.76M Sell
14,900
-300
-2% -$55.6K 0.13% 135
2014
Q3 		$2.52M Sell
15,200
-300
-2% -$49.3K 0.12% 143
2014
Q2 		$2.42M Sell
15,500
-200
-1% -$31.6K 0.11% 160
2014
Q1 		$2.39M Sell
15,700
-100
-0.6% -$15.9K 0.11% 155
2013
Q4 		$2.1M Buy
+15,800
New +$1.9M 0.1% 178

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Louisiana State Employees Retirement System's ALXN Position: Q3 2021 in Review

Louisiana State Employees Retirement System sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 25,200 shares — an estimated $4.63M sold.

Louisiana State Employees Retirement System first reported a position in ALXN in Q4 2013 and held it in 31 quarters. The position peaked at $4.63M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Louisiana State Employees Retirement System reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 25,200 Alexion Pharmaceuticals shares in Q3 2021, an estimated $4.63M.
  • Louisiana State Employees Retirement System first reported a position in Alexion Pharmaceuticals in Q4 2013 and held it in 31 quarters.
  • Louisiana State Employees Retirement System's Alexion Pharmaceuticals position peaked at $4.63M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Louisiana State Employees Retirement System's 13F filing for Q3 2021, filed 12 Oct 2021.